Prevalence of sexually transmitted infection in pregnancy and their association with adverse birth outcomes: a case-control study at Queen Elizabeth Central Hospital, Blantyre, Malawi.

Diagnostic Screening Programs NEISSERIA GONORRHOEAE PREGNANCY Prevalence SYPHILIS

Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
23 Jul 2024
Historique:
received: 31 01 2024
accepted: 29 06 2024
medline: 24 7 2024
pubmed: 24 7 2024
entrez: 23 7 2024
Statut: aheadofprint

Résumé

There are limited data on the epidemiology of sexually transmitted infections (STI) and their contribution to adverse birth outcomes (ABO) in sub-Saharan Africa (SSA). We performed a case-control study to assess the prevalence of STI and their association with ABO among women attending Queen Elizabeth Central Hospital, Blantyre, Malawi. A composite case definition for ABO included stillborn, preterm and low birthweight infants and infants admitted to neonatal intensive care unit within 24 hours of birth. Following recruitment of an infant with an ABO, the next born healthy infant was recruited as a control. Multiplex PCR for We included 259 cases and 251 controls. Maternal prevalence of STI was 3.1%, 2.7% and 17.1% for NG, CT and TV, respectively. Maternal prevalence of untreated syphilis was 2.0% and 6.1% for early stage and late/unknown stage, respectively; prevalence of treated syphilis was 2.7%. The HIV prevalence was 16.5%. HIV infection significantly increased the odds for ABO (OR=3.31; 95% CI 1.10 to 9.91) as did NG positivity (OR=4.30; 95% CI 1.16 to 15.99). We observed higher rates of ABO among women with untreated maternal syphilis (early: OR=7.13; 95% CI 0.87 to 58.39, late/unknown stage: OR=1.43; 95% CI 0.65 to 3.15). Maternal TV and CT infections were not associated with ABO. STI prevalence among pregnant women in Malawi is comparable to other SSA countries. HIV, NG and untreated syphilis prevalence was higher among women with ABO compared with women with healthy infants.

Sections du résumé

BACKGROUND BACKGROUND
There are limited data on the epidemiology of sexually transmitted infections (STI) and their contribution to adverse birth outcomes (ABO) in sub-Saharan Africa (SSA). We performed a case-control study to assess the prevalence of STI and their association with ABO among women attending Queen Elizabeth Central Hospital, Blantyre, Malawi.
METHODS METHODS
A composite case definition for ABO included stillborn, preterm and low birthweight infants and infants admitted to neonatal intensive care unit within 24 hours of birth. Following recruitment of an infant with an ABO, the next born healthy infant was recruited as a control. Multiplex PCR for
RESULTS RESULTS
We included 259 cases and 251 controls. Maternal prevalence of STI was 3.1%, 2.7% and 17.1% for NG, CT and TV, respectively. Maternal prevalence of untreated syphilis was 2.0% and 6.1% for early stage and late/unknown stage, respectively; prevalence of treated syphilis was 2.7%. The HIV prevalence was 16.5%. HIV infection significantly increased the odds for ABO (OR=3.31; 95% CI 1.10 to 9.91) as did NG positivity (OR=4.30; 95% CI 1.16 to 15.99). We observed higher rates of ABO among women with untreated maternal syphilis (early: OR=7.13; 95% CI 0.87 to 58.39, late/unknown stage: OR=1.43; 95% CI 0.65 to 3.15). Maternal TV and CT infections were not associated with ABO.
CONCLUSION CONCLUSIONS
STI prevalence among pregnant women in Malawi is comparable to other SSA countries. HIV, NG and untreated syphilis prevalence was higher among women with ABO compared with women with healthy infants.

Identifiants

pubmed: 39043612
pii: sextrans-2024-056130
doi: 10.1136/sextrans-2024-056130
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Charlotte van der Veer (C)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi cvdveer@liverpool.ac.uk.
Department of Children's and Women's Health, University of Liverpool, Liverpool, UK.

Chifundo Kondoni (C)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Annie Kuyere (A)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Fatima Mtonga (F)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Vita Nyasulu (V)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

George Shaba (G)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Chelsea Morroni (C)

Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
University of Edinburgh, Edinburgh, UK.

Gladys Gadama (G)

Queen Elizabeth Central Hospital, Blantyre, Malawi.

Luis Gadama (L)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Queen Elizabeth Central Hospital, Blantyre, Malawi.

Kondwani Kawaza (K)

Queen Elizabeth Central Hospital, Blantyre, Malawi.

Queen Dube (Q)

Queen Elizabeth Central Hospital, Blantyre, Malawi.

Neil French (N)

Institute of Infection, Veterinary and Ecological Science, University of Liverpool, Liverpool, UK.

David Lissauer (D)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Department of Children's and Women's Health, University of Liverpool, Liverpool, UK.

Bridget Freyne (B)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Children's Health Ireland, Dublin, Ireland.

Classifications MeSH